Evaluation of neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and mean platelet volume in patients with ankylosing spondylitis

Ayhan Aşkın

doi:10.17826/cukmedj.237486

TR EN

Ankilozan spondilit hastalarında nötrofil/lenfosit oranı, trombosit/lenfosit oranı ve ortalama trombosit hacminin değerlendirilmesi

Öz

Amaç: Bu çalışmanın amacı ankilozan spondilit hastalarında nötrofil/lenfosit oranı, trombosit/lenfosit oranı ve ortalama trombosit hacmini değerlendirmek ve klinik önemini araştırmaktır.

Gereç ve Yöntem: Çalışmaya 51 ankilozan spondilit hastası ve 53 sağlıklı kontrol alındı. Yaş, cinsiyet, hastalık süresi, Ankilozan Spondilit Aktivite Indeksi skoru, total lökosit sayısı, nötrofil, trombosit, lenfosit sayısı, C-reaktif protein, sedimantasyon, nötrofil/lenfosit oranı, trombosit/lenfosit oranı ve ortalama trombosit hacmi değerleri retrospektif olarak analiz edildi.

Bulgular: Bu çalışmada ankilozan spondilit hastalarında kontrollere göre nötrofil/lenfosit oranı, trombosit/lenfosit oranı ve ortalama trombosit hacmi değerlerinde anlamlı farklılık tespit edildi. Aktif ankilozan spondilit grubunda inaktif gruba göre nötrofil/lenfosit oranı, trombosit/lenfosit oranı ve ortalama trombosit hacmi değeri arasında anlamlı farklılık bulundu.

Sonuç: Klinisyenler ankilozan spondilit hastalarında nötrofil/lenfosit oranı, trombosit/lenfosit oranı ve ortalama trombosit hacmi değerlerini hastalık aktivitesini belirlemede kullanabilirler ve bu kolayca belirlenebilir ölçümler, objektif, basit ve kolay ulaşılabilirdir, aynı zamanda herhangi bir ek maliyete de yol açmazlar.

Anahtar Kelimeler

Ankilozan spondilit,nörofil/lenfosit oranı,trombosit/lenfosit oranı,ortalama trombosit hacmi

Evaluation of neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and mean platelet volume in patients with ankylosing spondylitis

Abstract

Purpose: The purpose of the present study was to evaluate neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and mean platelet volume levels in ankylosing spondylitis patients and explore their clinical significance.

Material and Methods: The study included 51 patients with AS and 53 healthy individuals. Age, sex, duration of disease, Bath Ankylosing Spondylitis Activity Index score, total white blood counts, neutrophil, platelet, lymphocyte counts, C-reactive protein, sedimantation, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and mean platelet volume values of the patients were analyzed retrospectively.

Results: The present study found a significantly different neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and mean platelet volume values in patients with ankylosing spondylitis when compared to the control group. We found a significantly different neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and mean platelet volume values in patients with active phase of ankylosing spondylitis when compared to the inactive group.

Conclusion: Clinicians may use neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and mean platelet volume values to evaluate disease activity in ankylosing spondylitis since these easily determinable measurements are objective, simple and readily available and also do not lead to any additional cost

Keywords

Ankylosing Spondylitis,neutrophil-to-lymphocyte ratio,platelet-to-lymphocyte ratio,mean platelet volume

Kaynakça

Braun J, Sieper J. Ankylosing spondylitis. Lancet. 2007;369:1379-90.
Dougados M, Baeten D. Spondyloarthritis. Lancet. 2011;377:2127-37.
Spoorenberg A, van der Heijde D, de Klerk E, Dougados M, de Vlam K, Mielants H et al. Relative value of erythrocyte sedimentation rate and C- reactive protein in assessment of disease activity in ankylosing spondylitis. J Rheumatol. 1999;26:980e4.
de Vries MK, van Eijk IC, van der Horst-Bruinsma IE, Peters MJ, Nurmohamed MT, Dijkmans BA et al. Erythrocyte sedimentation rate, C-reactive protein level, and serum amyloid a protein for patient selection and monitoring of anti-tumor necrosis factor treatment in ankylosing spondylitis. Arthritis Rheum. 2009;61:1484-90.
Dernis E, Lavie F, Pavy S, Wendling D, Flipo RM, Saraux A et al. Clinical and laboratory follow-up for treating and monitoring patients with ankylosing spondylitis: development of recommendations for clinical practice based on published evidence and expert opinion. Joint Bone Spine. 2007;74:330-7.
Colglazier CL, Sutej PG. Laboratory testing in the rheumatic diseases: a practical review. South Med J. 2005;98:185-91.
Waits JB. Rational use of laboratory testing in the initial evaluation of soft tissue and joint complaints. Prim Care. 2010;37:673-89.
Gasparyan AY, Ayvazyan L, Mikhailidis DP, Kitas GD. Mean platelet volume: a link between thrombosis and inflammation? Curr Pharm Des. 2011;17:47-58.
Zareifar S, Farahmand Far MR, Golfeshan F, Cohan N. Changes in platelet count and mean platelet volume during infectious and inflammatory disease and their correlation with ESR and CRP. J Clin Lab Anal. 2014;28:245-8.
Şahin A, Yetişgin A, Şahin M, Durmaz Y, Cengiz AK. Can mean platelet volume be a surrogate marker of inflammation in rheumatic diseases? West Indian Med J 2015; doi: 10.7727/wimj.2014.202.

Mercan R, Bitik B, Tufan A, Bozbulut UB, Atas N, Ozturk MA et al. The association between neutrophil/lymphocyte ratio and disease activity in rheumatoid arthritis and ankylosing spondylitis. J Clin Lab Anal. 2015; doi: 10.1002/jcla.21908.
Uslu AU, Küçük A, Şahin A, Ugan Y, Yılmaz R, Güngör T et al. Two new inflammatory markers associated with Disease Activity Score-28 in patients with rheumatoid arthritis: neutrophil-lymphocyte ratio and platelet-lymphocyte ratio. Int J Rheum Dis. 2015;18:731-5.
Gökmen F, Akbal A, Reşorlu H, Gökmen E, Güven M, Aras AB et al. Neutrophil-lymphocyte ratio connected to treatment options and ınflammation markers of ankylosing spondylitis. J Clin Lab Anal. 2015;29:294-8.
Fu H, Qin B, Hu Z, Ma N, Yang M, Wei T et al. Neutrophil-and platelet-to-lymphocyte ratios are correlated with disease activity in rheumatoid arthritis. Clin Lab. 2015;61:269-73.
Qin B, Ma N, Tang Q, Wei T, Yang M, Fu H et al. Neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR) were useful markers in assessment of inflammatory response and disease activity in SLE patients. Mod Rheumatol. 2015;25:1- 16.
Boyraz I, Koç B, Boyacı A, Tutoğlu A, Sarman H, Ozkan H. Ratio of neutrophil/lymphocyte and platelet/lymphocyte in patient with ankylosing spondylitis that are treating with anti-TNF. Int J Clin Exp Med. 2014;15:2912-5.
Templeton AJ, Ace O, McNamara MG, Al-Mubarak M, Vera-Badillo FE, Hermanns T et al. Prognostic role of platelet to lymphocyte ratio in solid tumors: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev. 2014;23:1204-12.
Xin-Ji Z, Yong-Gang L, Xiao-Jun S, Xiao-Wu C, Dong Z, Da-Jian Z. The prognostic role of neutrophils to lymphocytes ratio and platelet count in gastric cancer: A meta-analysis. Int J Surg. 2015;21:84-91.
Verdoia M, Schaffer A, Barbieri L, Aimaretti G, Marino P, Sinigaglia F. Impact of diabetes on neutrophil-to-lymphocyte ratio and its relationship to coronary 2015;41:304-11. Diabetes Metab.
Sari I, Sunbul M1, Mammadov C, Durmus E, Bozbay M, Kivrak T et al. Relation of neutrophil-to- lymphocyte and platelet-to-lymphocyte ratio with coronary artery disease severity in patients undergoing coronary angiography. Kardiol Pol. 2015;73:1310-6.
Zahorec R. Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy. 2001;102:5-14.
Çoşkun BN, Öksüz MF, Ermurat S, Tufan AN, Oruçoğlu N, Doğan A et al. Neutrophil lymphocyte ratio can be a valuable marker indefining disease activity in patients who have started anti tumor necrosis factor (TNF) drugs for ankylosing spondylitis. Eur J Rheumatol. 2014;1:101-5.
Wu Y, Chen Y, Yang X, Chen L, Yang Y. Neutrophil-to-lymphocyte ratio (NLR) and platelet- to-lymphocyte ratio (PLR) were associated with disease activity in patients with systemic lupus erythematosus. Int Immunopharmacol. 2016; 36:94- 9.
Uluca Ü, Ece A, Şen V, Karabel D, Yel S, Güneş A et al. Usefulness of mean platelet volume and neutrophil-to-lymphocyte ratio for evaluation of children with familial mediterranean fever. Med Sci Monit. 2014;20:1578-82.
Alan S, Tuna S, Türkoğlu EB. The relation of neutrophil-to-lymphocyte lymphocyte ratio, and mean platelet volume with the presence and severity of Behçet’s syndrome. Kaohsiung J Med Sci. 2015;31:626-31. platelet-to
Kim DS, Shin D, Lee MS, Kim HJ, Kim DY, Kim SM. Assessments of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in Korean patients with psoriasis vulgaris and psoriatic arthritis. J Dermatol. 2016;43:305-10.
Bath PM, Butterworth RJ. Platelet size: measurement, physiology and vascular disease. Blood Coagul Fibrinolysis. 1996;7:157-61.
Yazici S, Yazici M, Erer B, Erer B, Calik Y, Bulur S et al. The platelet functions in patients with ankylosing spondylitis, anti- TNF-alpha therapy decreases the mean platelet volume and platelet mass. Platelets. 2010;21:126e31.
Güneş A, Ece A, Şen V, Uluca Ü, Aktar F, Tan İ. Correlation of mean platelet volume, neutrophil-to- lymphocyte ratio, and disease activity in children with juvenile ıdiopathic arthritis. Int J Clin Exp Med. 2015;8:11337-41.
Zareifar S, Farahmand Far MR, Golfeshan F, Cohan N. Changes in platelet count and mean platelet volume during infectious and inflammatory disease and their correlation with ESR and CRP. J Clin Lab Anal. 2014;28:245-8.

Ayrıntılar

Birincil Dil

İngilizce

Konular

Sağlık Kurumları Yönetimi

Bölüm

Araştırma Makalesi

Yazarlar

Ayhan Aşkın Bu kişi benim

Yayımlanma Tarihi

30 Eylül 2016

Gönderilme Tarihi

10 Haziran 2016

Kabul Tarihi

-

Yayımlandığı Sayı

Yıl 2016 Cilt: 41 Sayı: 3

DOI

https://doi.org/10.17826/cukmedj.237486

IZ

https://izlik.org/JA47ZB33NU

MLA

Aşkın, Ayhan. “Evaluation of neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and mean platelet volume in patients with ankylosing spondylitis”. Cukurova Medical Journal, c. 41, sy 3, Eylül 2016, ss. 479-84, doi:10.17826/cukmedj.237486.